MedTrace Logo

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

NCT04371471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2022-07-19

Study results available
· View outcomes & findings →

Summary

During this pandemic period, the goal of the health care system is to optimize the use of intensive care services for patients infected with SARS-CoV-2, given the frequency of complications that can lead to high mortality.

When patients with suspected or confirmed COVID-19 are admitted to hospital, whether or not they are symptomatic, there is currently no method to predict who will progress to complications requiring the use of intensive measures in 24-48 hours.

Conditions

  • SARS-CoV-2 Acute Respiratory Disease
  • Covid19

Interventions

DIAGNOSTIC_TEST

STC-19 score

Score calculated by an algorithm using a vital sign (systolic blood pressure) and biomarkers (complete blood count with differential)

Sponsors & Collaborators

  • NumaHealth International

    collaborator INDUSTRY

  • Groupe Hospitalier de la Rochelle Ré Aunis

    lead OTHER

Principal Investigators

  • David Chalvet, MD · Numa Health International

  • Kamyar M. Hedayat, MD · Numa Health International

  • Jean-Claude Lapraz, MD · Numa Health International

  • Serge Bénéteaud, MD · Groupe Hospitalier de la Rochelle Ré Aunis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04371471 on ClinicalTrials.gov